Second-line virologic failure and elevated bilirubin as a potential surrogate marker of ART adherence among people living with HIV in Eastern Uganda

dc.contributor.authorSimiyu Melap Lynnet
dc.contributor.authorJacob Stanley Iramiot
dc.contributor.authorRebecca Nekaka
dc.contributor.authorPatrick Okware
dc.contributor.authorMary Abwola Olwedo
dc.contributor.authorJoshua Epuitai
dc.contributor.authorPaul Oboth
dc.contributor.authorHerbert Itabangi
dc.contributor.authorLydia V. N. Ssenyonga
dc.contributor.authorJulius Nteziyaremye
dc.contributor.authorDavid Okia
dc.date.accessioned2026-06-10T13:32:44Z
dc.date.available2026-06-10T13:32:44Z
dc.date.issued2026
dc.descriptionEthical clearance was obtained from the Mbale Regional Referral Hospital Research Ethics Committee (MRRH-2022-204). Permission to collect data was sought from the administration of MRRH and Tororo Hospital. Written informed consent was obtained from all participants who completed the questionnaires individually to ensure privacy, confidentiality, and anonymity. Participation was voluntary, and participants could withdraw from the study at any time without penalty
dc.description.abstractSecond-line antiretroviral therapy (ART) failure remains a challenge in HIV Programs. We conducted a cross sectional study among people living with HIV on second-line ART in Eastern Uganda to determine the prevalence and associated factors of virological failure and to assess elevated serum bilirubin as a surrogate marker of adherence. The prevalence of virological failure was 7.5%. Elevated bilirubin showed poor sensitivity and specificity for predicting adherence or virological failure. The findings highlight the need for routine viral load monitoring, as bilirubin is not a reliable surrogate marker of treatment adherence or virological failure. Keywords Second-line virological failure, Elevated bilirubin, And adherence
dc.description.sponsorshipThis research did not receive specific funding. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health
dc.identifier.citationLynnet, S. M., Iramiot, J. S., Nekaka, R., Okware, P., Olwedo, M. A., Epuitai, J., ... & Okia, D. (2026). Second-line virologic failure and elevated bilirubin as a potential surrogate marker of ART adherence among people living with HIV in Eastern Uganda. AIDS Research and Therapy.
dc.identifier.issnhttps://doi.org/10.1186/s12981-026-00861-w
dc.identifier.urihttps://ir.sun.ac.ug/handle/123456789/157
dc.language.isoen
dc.publisherSpringer Nature
dc.titleSecond-line virologic failure and elevated bilirubin as a potential surrogate marker of ART adherence among people living with HIV in Eastern Uganda
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
12981_2026_Article_861.pdf
Size:
723.05 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: